Why insider trading matters?

When insiders buy shares on the open market, this can thus be regarded as a strong endorsement by those that know the company the best -- they are literally betting their own money on the company's future. Insider selling, however, is not necessarily meaningful in any way, as there is a range of reasons for insiders to liquidate (some) of the shares they own.

- Seeking Alpha
MANNKIND CORP (MNKD)
Sector: Healthcare; Industry: Biotechnology

MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for diabetes and pulmonary arterial hypertension patients in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2022-07-31 Binder Steven B. Chief Financial Officer Buy 791 $2.93 $2,318 No
2022-07-31 Castagna Michael Chief Executive Officer Buy 3,147 $2.93 $9,221 No
2022-07-31 Galindo Alejandro EVP Endocrine Business Unit Buy 5,000 $2.93 $14,650 No
2022-02-28 Galindo Alejandro Chief Commercial Officer Buy 36,900 $2.71 $99,999 No
2022-02-28 HOOPER ANTHONY C Director Buy 40,000 $2.71 $108,400 No
2022-02-28 Castagna Michael Chief Executive Officer Buy 27,675 $2.71 $74,999 No
2022-01-31 Galindo Alejandro Chief Commercial Officer Buy 1,804 $3.17 $5,719 No
2022-01-31 Binder Steven B. Chief Financial Officer Buy 711 $3.17 $2,254 No
2022-01-31 Galindo Alejandro Chief Commercial Officer Buy 2,334 $3.17 $7,399 No
2022-01-31 Tross Stuart A Chief People & Workpl Officer Buy 4,254 $3.17 $13,485 No
2022-01-31 Castagna Michael Chief Executive Officer Buy 2,334 $3.17 $7,399 No
2021-03-05 Castagna Michael Chief Executive Officer Buy 3,000 $3.38 $10,140 No
2021-01-31 Binder Steven B. Chief Financial Officer Buy 1,557 $1.33 $2,071 No
2021-01-31 Tross Stuart A Chief People & Workpl Officer Buy 5,000 $1.33 $6,650 No
2020-12-08 Galindo Alejandro Chief Commercial Officer Buy 34,602 $2.89 $100,000 No
2018-11-14 Galindo Alejandro Chief Commercial Officer Buy 34,602 $2.89 $100,000 No
2020-07-31 Binder Steven B. Chief Financial Officer Buy 1,522 $1.25 $1,902 No
2020-07-31 Tross Stuart A Chief People & Workpl Officer Buy 5,000 $1.25 $6,250 No
2020-07-31 Kendall David M Chief Medical Officer Buy 4,041 $1.25 $5,051 No
2020-07-31 Castagna Michael Chief Executive Officer Buy 5,000 $1.25 $6,250 No
2020-06-15 Castagna Michael Chief Executive Officer Buy 40,431 $1.47 $59,434 No
2020-01-31 Tross Stuart A Chief People & Workpl Officer Buy 5,000 $0.95 $4,750 No
2020-01-31 McCauley Patrick Chief Commercial Officer Buy 5,000 $0.95 $4,750 No
2020-01-31 Kendall David M Chief Medical Officer Buy 2,304 $0.95 $2,189 No
2020-01-31 Castagna Michael Chief Executive Officer Buy 5,000 $0.95 $4,750 No
2020-01-31 Binder Steven B. Chief Financial Officer Buy 2,168 $0.95 $2,060 No
2019-07-31 Tross Stuart A Chief People & Workpl Officer Buy 5,000 $0.95 $4,750 No
2019-07-31 McCauley Patrick Chief Commercial Officer Buy 5,000 $0.95 $4,750 No
2019-07-31 Kendall David M Chief Medical Officer Buy 5,000 $0.95 $4,750 No
2019-07-31 Barton Courtney Chief Compl & Privacy Officer Buy 4,011 $0.95 $3,810 No

Insider Smart

VBI Vaccines Inc (VBIV) - Since 10%-owner Perceptive Advisor LCC increased their holding in April, the stock have double the price. Impressive!

Insider Smart

Enphase Energy, Inc (ENPH) - Watch for CEO Kothandaraman Badrinarayanan and CFO Branderiz Eric, their trading have a good pattern you can't miss, very well timed buy low and sell high.